Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products. It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.
Metrics to compare | CORL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCORLPeersSector | |
---|---|---|---|---|
P/E Ratio | 10.5x | 29.5x | −0.7x | |
PEG Ratio | −0.50 | 0.17 | 0.00 | |
Price/Book | 0.9x | 3.4x | 2.6x | |
Price / LTM Sales | 1.8x | 2.4x | 3.4x | |
Upside (Analyst Target) | - | 18.5% | 35.7% | |
Fair Value Upside | Unlock | 0.5% | 4.1% | Unlock |